GlassScriptPhysician profile
Danny M Colton
NPI 1831191956
$10,881.79
in general payments reported to CMS, 2019-2025
11 companies · $3,294 in 2025
The $3,294 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,259 · 2021: $30.22 · 2022: $936 · 2023: $4,974 · 2024: $389 · 2025: $3,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,750 · Travel and Lodging: $2,312 · Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,750.00 |
| Travel and Lodging | $2,312.47 |
| Food and Beverage | $594.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,333.36 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,218.53 | 2023 | |
| Covidien LP | $1,109.15 | 2019 | |
| Medtronic, INC. | $820.36 | 2022 | |
| Organogenesis INC. | $124.78 | 2019 | |
| Smith+Nephew, INC. | $115.22 | 2022 | |
| Ethicon US, LLC | $68.78 | 2023-2024 | Surgiflo Hemostatic Matrix, Surgicel Nu-Knit, N/A |
| Ethicon INC. | $36.65 | 2023 | Echelon Endopath, Vistaseal, Dermabond Prineo |
| Kci USA, INC. | $24.74 | 2019 | |
| Innocoll Pharmaceuticals Limited | $17.94 | 2021 | |
| Trevena, INC. | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Colton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.